Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Gliosarcoma × Hyperbaric Oxygenation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Breast Neoplasms 3 Sarcoma 2 Neoplasms, Plasma Cell 2 Multiple Myeloma 2 Squamous Cell Carcinoma of Head and Neck 1 Radiation Pneumonitis 1 Radiation Injuries 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Myelodysplastic Syndromes 1 Lymphoma 1 Hodgkin Disease 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Glioblastoma 1 Fibrosis 1 Carcinoma, Squamous Cell 1 Carcinoma, Hepatocellular 1

Interventions

Temozolomide 80 Radiotherapy 47 Bevacizumab 29 Irinotecan 18 Radiation 15 Erlotinib Hydrochloride 14 Carmustine 13 Magnetic Resonance Spectroscopy 12 O(6)-benzylguanine 10 Chemotherapy, Adjuvant 10 sargramostim 8 Thalidomide 8 Imatinib Mesylate 8 Carboplatin 8 Gene Expression Profiling 6 Filgrastim 6 Drug Therapy 6 Surgical Procedures, Operative 5 Radiotherapy, Intensity-Modulated 5 Hydroxyurea 5 Gefitinib 5 pembrolizumab 4 aldesleukin 4 Topotecan 4 Immunohistochemistry 4 Etoposide 4 Dasatinib 4 Celecoxib 4 Biopsy 4 Aminolevulinic Acid 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00936052 2010-07-16

HBO

Neurological Surgery, P.C.

Phase 2 Unknown

Glioblastoma, Sarcoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡